Observational Ocrelizumab MS Verismo Study
Brief description of study
The purpose of this study is to obtain additional safety information on OCREVUS® and to gain insights about how well OCREVUS® is tolerated by patients to whom it is prescribed in routine practice. There are many factors that can only be studied in everyday practice, particularly if many patients participate; for example, little known side effects of the medication may be detected, the influence of dose changes or a concomitant medication can be observed. This information will help doctors to know better how to use OCREVUS® and may optimize the treatment of patients like you.
Clinical Study Identifier: s21-00114
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
